Primary immunodeficiencies (PIDs) and rheumatic diseases have long been considered distinct clinical entities, yet growing evidence reveals substantial ...
On April 3, 2025, the White House Office of Management and Budget (OMB) released two memoranda, M-25-21 and M-25-22, regarding federal agencies’ ...
Continuous glucose monitoring (CGM) is underutilized in non-insulin-treated type 2 diabetes (T2D) despite evidence of ...